ARCHIVES

FDA Approvals: Lymphoseek Label Updated to Include Head and Neck SCC

This article is from The Cancer Letter archive.

Vol. 40 No. 26 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

New Clinical Trials Monitoring Program To Site Visit PIs Every Three Years

July 30, 1982

NCI RFPs Available. RFAs Available. Program Announcements.

January 14, 2000

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

February 26, 2010

Proof of principle needed before launching “big science” program, advisors say.

March 11, 2005

In Brief: alberts elected To Second Term as NAS President

February 19, 1999

Abstracts Of Papers From Therapeutic Radiology Meeting

November 21, 1975